News

The collaboration will combine Lundbeck's expertise in the treatment of psychiatric and neurological disorders with IBM's cognitive and knowledge-based analytics to foster the discovery and development of new

The options range from retaining the business to separation through a capital markets transaction in order to identify how to best maximize value for the company’s shareholders. Alcon

The project, entitled “Exploitation of transport mechanisms for novel Gram-negative antibiotic drug discovery”, will leverage Discuva’s proprietary SATIN technology to explore new biological targets and deliver novel drug

Connect Biopharmaceuticals, Ltd., a clinical-stage company that discovers and develops novel immune modulators for the treatment of autoimmune diseases and cancer, today announces the completion of a $20

Dubbed ReLive, the phase 3 trial will evaluate the efficacy of intravenous (IV) administration of Livatag for treating the aggressive form of primary liver cancer. It will have patients

Guided by an experienced management team and preeminent board members and scientific advisors, Cue will use the proceeds to accelerate development of its novel platform of T cell

Under the initial terms of the partnership, ELC Group has commissioned PSR Group to develop 10 new products for human use, targeting therapeutic areas including oncology, pain management,

Intrexon intends to integrate and expand upon GenVec’s expertise in adenoviral vectors and cGMP drug product manufacturing to enhance its broad gene transfer capabilities that encompass multiple viral

The trial, Maestro, had enrolled 226 patients, with 135 of them in Functional Class II and was randomized in a 1:1 ratio. While one patient group was subjected to